Published in Infect Immun on August 01, 1994
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev (2005) 6.02
Integration of multiple domains in a two-component sensor protein: the Bordetella pertussis BvgAS phosphorelay. EMBO J (1996) 2.41
Human Bordetella bronchiseptica infection related to contact with infected animals: persistence of bacteria in host. J Clin Microbiol (1995) 1.84
Pregenomic comparative analysis between bordetella bronchiseptica RB50 and Bordetella pertussis tohama I in murine models of respiratory tract infection. Infect Immun (1999) 1.83
Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection. Infect Immun (2000) 1.77
Probing the function of Bordetella bronchiseptica adenylate cyclase toxin by manipulating host immunity. Infect Immun (1999) 1.76
Filamentous hemagglutinin of Bordetella bronchiseptica is required for efficient establishment of tracheal colonization. Infect Immun (1998) 1.74
Species- and strain-specific control of a complex, flexible regulon by Bordetella BvgAS. J Bacteriol (2006) 1.70
The Bvg virulence control system regulates biofilm formation in Bordetella bronchiseptica. J Bacteriol (2004) 1.60
Genetic basis for lipopolysaccharide O-antigen biosynthesis in bordetellae. Infect Immun (1999) 1.59
Alterations in Vibrio fischeri motility correlate with a delay in symbiosis initiation and are associated with additional symbiotic colonization defects. Appl Environ Microbiol (2002) 1.59
Modeling systems-level regulation of host immune responses. PLoS Comput Biol (2007) 1.56
SirA orthologs affect both motility and virulence. J Bacteriol (2001) 1.50
Role of a putative polysaccharide locus in Bordetella biofilm development. J Bacteriol (2006) 1.50
The Bordetella Bps polysaccharide is critical for biofilm development in the mouse respiratory tract. J Bacteriol (2007) 1.47
Neither the Bvg- phase nor the vrg6 locus of Bordetella pertussis is required for respiratory infection in mice. Infect Immun (1998) 1.41
Bordetella pertussis pathogenesis: current and future challenges. Nat Rev Microbiol (2014) 1.40
Role of Bordetella bronchiseptica fimbriae in tracheal colonization and development of a humoral immune response. Infect Immun (2000) 1.39
Role of Bordetella O antigen in respiratory tract infection. Infect Immun (2003) 1.32
The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance. Infect Immun (2006) 1.31
FlrA, a sigma54-dependent transcriptional activator in Vibrio fischeri, is required for motility and symbiotic light-organ colonization. J Bacteriol (2003) 1.30
Bordetella filamentous hemagglutinin plays a critical role in immunomodulation, suggesting a mechanism for host specificity. Proc Natl Acad Sci U S A (2005) 1.29
Comparative toll-like receptor 4-mediated innate host defense to Bordetella infection. Infect Immun (2005) 1.23
Contribution of regulation by the bvg locus to respiratory infection of mice by Bordetella pertussis. Infect Immun (1998) 1.19
Pertactin is required for Bordetella species to resist neutrophil-mediated clearance. Infect Immun (2010) 1.17
Selective ligand recognition by a diversity-generating retroelement variable protein. PLoS Biol (2008) 1.17
DsbA and DsbC are required for secretion of pertussis toxin by Bordetella pertussis. Infect Immun (2002) 1.14
Comparative phenotypic analysis of the Bordetella parapertussis isolate chosen for genomic sequencing. Infect Immun (2002) 1.13
A second two-component regulatory system of Bordetella bronchiseptica required for bacterial resistance to oxidative stress, production of acid phosphatase, and in vivo persistence. Infect Immun (1998) 1.11
bvg Repression of alcaligin synthesis in Bordetella bronchiseptica is associated with phylogenetic lineage. J Bacteriol (1995) 1.11
Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopN. J Exp Med (2009) 1.11
Unexpected similarities between Bordetella avium and other pathogenic Bordetellae. Infect Immun (2003) 1.10
The Bordetella type III secretion system effector BteA contains a conserved N-terminal motif that guides bacterial virulence factors to lipid rafts. Cell Microbiol (2009) 1.10
Interactions between partner switcher orthologs BtrW and BtrV regulate type III secretion in Bordetella. J Bacteriol (2005) 1.08
pagP is required for resistance to antibody-mediated complement lysis during Bordetella bronchiseptica respiratory infection. Infect Immun (2004) 1.06
The BvgAS signal transduction system regulates biofilm development in Bordetella. J Bacteriol (2005) 1.05
Characterization of FimY as a coactivator of type 1 fimbrial expression in Salmonella enterica serovar Typhimurium. Infect Immun (2000) 1.04
Replacement of adenylate cyclase toxin in a lineage of Bordetella bronchiseptica. J Bacteriol (2008) 1.03
Autoregulation is essential for precise temporal and steady-state regulation by the Bordetella BvgAS phosphorelay. J Bacteriol (2006) 1.03
Virulence factor secretion and translocation by Bordetella species. Curr Opin Microbiol (2009) 1.02
Transcriptional profiling of the iron starvation response in Bordetella pertussis provides new insights into siderophore utilization and virulence gene expression. J Bacteriol (2011) 1.02
Role of FimW, FimY, and FimZ in regulating the expression of type i fimbriae in Salmonella enterica serovar Typhimurium. J Bacteriol (2009) 1.02
Contribution of Bordetella bronchiseptica filamentous hemagglutinin and pertactin to respiratory disease in swine. Infect Immun (2009) 1.01
Norepinephrine mediates acquisition of transferrin-iron in Bordetella bronchiseptica. J Bacteriol (2008) 1.01
Inefficient Toll-like receptor-4 stimulation enables Bordetella parapertussis to avoid host immunity. PLoS One (2009) 1.01
CXCR3 and its ligands participate in the host response to Bordetella bronchiseptica infection of the mouse respiratory tract but are not required for clearance of bacteria from the lung. Infect Immun (2005) 1.01
Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity. Infect Immun (2005) 1.00
Histidine-containing phosphotransfer protein-B (HptB) regulates swarming motility through partner-switching system in Pseudomonas aeruginosa PAO1 strain. J Biol Chem (2011) 1.00
Suppression of NF-kappaB-mediated beta-defensin gene expression in the mammalian airway by the Bordetella type III secretion system. Cell Microbiol (2005) 1.00
Use of pertussis toxin encoded by ptx genes from Bordetella bronchiseptica to model the effects of antigenic drift of pertussis toxin on antibody neutralization. Infect Immun (2000) 1.00
Analysis of proteins encoded by the ptx and ptl genes of Bordetella bronchiseptica and Bordetella parapertussis. Infect Immun (1996) 0.99
Bacteriophage-mediated competition in Bordetella bacteria. Proc Biol Sci (2006) 0.99
Growth phase- and nutrient limitation-associated transcript abundance regulation in Bordetella pertussis. Infect Immun (2006) 0.99
Differential regulation of the Bordetella bipA gene: distinct roles for different BvgA binding sites. J Bacteriol (2002) 0.97
Role of the type III secretion system in a hypervirulent lineage of Bordetella bronchiseptica. Infect Immun (2009) 0.97
Cavitary pneumonia in an AIDS patient caused by an unusual Bordetella bronchiseptica variant producing reduced amounts of pertactin and other major antigens. J Clin Microbiol (2002) 0.96
Identification of two bvg-repressed surface proteins of Bordetella pertussis. Infect Immun (1995) 0.95
Characterization of the filamentous hemagglutinin-like protein FhaS in Bordetella bronchiseptica. Infect Immun (2005) 0.95
Construction and validation of a first-generation Bordetella bronchiseptica long-oligonucleotide microarray by transcriptional profiling the Bvg regulon. BMC Genomics (2007) 0.95
Bordetella bronchiseptica adherence to cilia is mediated by multiple adhesin factors and blocked by surfactant protein A. Infect Immun (2005) 0.95
Comparison of bipA alleles within and across Bordetella species. Infect Immun (2003) 0.94
BvgAS is sufficient for activation of the Bordetella pertussis ptx locus in Escherichia coli. J Bacteriol (1995) 0.94
Molecular evolution of the two-component system BvgAS involved in virulence regulation in Bordetella. PLoS One (2009) 0.93
Generating super-shedders: co-infection increases bacterial load and egg production of a gastrointestinal helminth. J R Soc Interface (2012) 0.93
Differential regulation of Bvg-activated virulence factors plays a role in Bordetella pertussis pathogenicity. Infect Immun (2001) 0.92
Evaluation of the role of the Bvg intermediate phase in Bordetella pertussis during experimental respiratory infection. Infect Immun (2005) 0.92
The Bordetella pertussis model of exquisite gene control by the global transcription factor BvgA. Microbiology (2012) 0.91
Reduced virulence of a Bordetella bronchiseptica siderophore mutant in neonatal swine. Infect Immun (2001) 0.91
The type III secreted protein BopD in Bordetella bronchiseptica is complexed with BopB for pore formation on the host plasma membrane. J Bacteriol (2004) 0.90
Comparative role of immunoglobulin A in protective immunity against the Bordetellae. Infect Immun (2007) 0.90
Interactions of pulmonary collectins with Bordetella bronchiseptica and Bordetella pertussis lipopolysaccharide elucidate the structural basis of their antimicrobial activities. Infect Immun (2004) 0.89
Expression of the primary carbohydrate component of the Bordetella bronchiseptica biofilm matrix is dependent on growth phase but independent of Bvg regulation. J Bacteriol (2006) 0.89
The host defense peptide beta-defensin 1 confers protection against Bordetella pertussis in newborn piglets. Infect Immun (2006) 0.89
Enzymatic modification of lipid A by ArnT protects Bordetella bronchiseptica against cationic peptides and is required for transmission. Infect Immun (2013) 0.89
Use of a genetically defined double mutant strain of Bordetella bronchiseptica lacking adenylate cyclase and type III secretion as a live vaccine. Infect Immun (2007) 0.89
Bordetella bronchiseptica flagellin is a proinflammatory determinant for airway epithelial cells. Infect Immun (2005) 0.89
Downregulation of mitogen-activated protein kinases by the Bordetella bronchiseptica Type III secretion system leads to attenuated nonclassical macrophage activation. Infect Immun (2005) 0.88
Phenotypic modulation of the virulent Bvg phase is not required for pathogenesis and transmission of Bordetella bronchiseptica in swine. Infect Immun (2011) 0.88
A highly adherent phenotype associated with virulent Bvg+-phase swine isolates of Bordetella bronchiseptica grown under modulating conditions. Infect Immun (1997) 0.88
Characterization of BrkA expression in Bordetella bronchiseptica. Infect Immun (1998) 0.88
Contribution of Bordetella filamentous hemagglutinin and adenylate cyclase toxin to suppression and evasion of interleukin-17-mediated inflammation. Infect Immun (2012) 0.88
A role for lipopolysaccharide in turkey tracheal colonization by Bordetella avium as demonstrated in vivo and in vitro. Mol Microbiol (2000) 0.87
Different effects of whole-cell and acellular vaccines on Bordetella transmission. J Infect Dis (2014) 0.87
Strain-dependent role of BrkA during Bordetella pertussis infection of the murine respiratory tract. Infect Immun (2004) 0.87
Bordetella pertussis infection or vaccination substantially protects mice against B. bronchiseptica infection. PLoS One (2009) 0.87
Molecular characterization of two Bordetella bronchiseptica strains isolated from children with coughs. J Clin Microbiol (1997) 0.86
Immune regulation of a chronic bacteria infection and consequences for pathogen transmission. BMC Microbiol (2010) 0.86
Role of Vpma phase variation in Mycoplasma agalactiae pathogenesis. FEMS Immunol Med Microbiol (2012) 0.86
A Type VI secretion system encoding locus is required for Bordetella bronchiseptica immunomodulation and persistence in vivo. PLoS One (2012) 0.85
Bordetella bronchiseptica expresses the fimbrial structural subunit gene fimA. J Bacteriol (1997) 0.84
In vivo colonization profile study of Bordetella bronchiseptica in the nasal cavity. FEMS Microbiol Lett (2007) 0.84
The type III secreted protein BspR regulates the virulence genes in Bordetella bronchiseptica. PLoS One (2012) 0.84
Evidence for horizontal gene transfer of two antigenically distinct O antigens in Bordetella bronchiseptica. Infect Immun (2009) 0.84
Microarray and functional analysis of growth phase-dependent gene regulation in Bordetella bronchiseptica. Infect Immun (2009) 0.83
The Bordetella bronchiseptica type III secretion system is required for persistence and disease severity but not transmission in swine. Infect Immun (2013) 0.83
Role of pagL and lpxO in Bordetella bronchiseptica lipid A biosynthesis. J Bacteriol (2011) 0.83
Expression of hurP, a gene encoding a prospective site 2 protease, is essential for heme-dependent induction of bhuR in Bordetella bronchiseptica. J Bacteriol (2007) 0.83
Bordetella pertussis acquires resistance to complement-mediated killing in vivo. Infect Immun (2003) 0.82
Comparative analyses of a cystic fibrosis isolate of Bordetella bronchiseptica reveal differences in important pathogenic phenotypes. Infect Immun (2014) 0.82
Post-assembly modification of Bordetella bronchiseptica O polysaccharide by a novel periplasmic enzyme encoded by wbmE. J Biol Chem (2008) 0.82
Protein phosphorylation and regulation of adaptive responses in bacteria. Microbiol Rev (1989) 20.50
Coordinate regulation and sensory transduction in the control of bacterial virulence. Science (1989) 10.59
A simple chemically defined medium for the production of phase I Bordetella pertussis. J Gen Microbiol (1970) 8.89
Tn5-induced mutations affecting virulence factors of Bordetella pertussis. Infect Immun (1983) 8.49
Virulence factors of Bordetella pertussis. Annu Rev Microbiol (1986) 6.41
Biology of Bordetella bronchiseptica. Microbiol Rev (1980) 5.31
Genetic analysis of phase change in Bordetella pertussis. Infect Immun (1984) 5.03
Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence. Proc Natl Acad Sci U S A (1989) 4.87
Sequences required for expression of Bordetella pertussis virulence factors share homology with prokaryotic signal transduction proteins. Proc Natl Acad Sci U S A (1989) 4.78
Antigenic modulation of Bordetella pertussis. J Hyg (Lond) (1960) 4.61
The calmodulin-sensitive adenylate cyclase of Bordetella pertussis: cloning and expression in Escherichia coli. Mol Microbiol (1988) 4.15
Two trans-acting regulatory genes (vir and mod) control antigenic modulation in Bordetella pertussis. J Bacteriol (1988) 3.88
Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes. J Bacteriol (1987) 3.44
Molecular cloning and characterization of protective outer membrane protein P.69 from Bordetella pertussis. Proc Natl Acad Sci U S A (1989) 3.13
Subcellular localization and immunological detection of proteins encoded by the vir locus of Bordetella pertussis. J Bacteriol (1991) 3.12
Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization. J Exp Med (1991) 2.79
Fimbrial phase variation in Bordetella pertussis: a novel mechanism for transcriptional regulation. EMBO J (1990) 2.53
The bvgAS locus negatively controls motility and synthesis of flagella in Bordetella bronchiseptica. J Bacteriol (1992) 2.33
Structural and genetic analysis of the bvg locus in Bordetella species. Mol Microbiol (1991) 2.09
Flagellin gene transcription in Bordetella bronchiseptica is regulated by the BvgAS virulence control system. J Bacteriol (1993) 1.94
Constitutive sensory transduction mutations in the Bordetella pertussis bvgS gene. J Bacteriol (1992) 1.91
Phase variants of Bordetella bronchiseptica arise by spontaneous deletions in the vir locus. Mol Microbiol (1989) 1.70
Autophosphorylation and phosphotransfer in the Bordetella pertussis BvgAS signal transduction cascade. Proc Natl Acad Sci U S A (1994) 1.65
Evaluation of Bordetella bronchiseptica vaccines in specific-pathogen-free piglets with bacterial cell surface antigens in enzyme-linked immunosorbent assay. Infect Immun (1985) 1.64
Adenylate cyclase activity of Bordetella organisms. I. Its production in liquid medium. Microbiol Immunol (1980) 1.52
Identification of a common enterobacterial flagellin epitope with a monoclonal antibody. J Gen Microbiol (1990) 1.40
Evidence that modulation requires sequences downstream of the promoters of two vir-repressed genes of Bordetella pertussis. J Bacteriol (1990) 1.35
Growth and survival of Bordetella bronchiseptica in natural waters and in buffered saline without added nutrients. Appl Environ Microbiol (1991) 1.33
Nucleotide sequence homology to pertussis toxin gene in Bordetella bronchiseptica and Bordetella parapertussis. Infect Immun (1987) 1.26
Virulence of Bordetella bronchiseptica: role of adenylate cyclase-hemolysin. Infect Immun (1993) 1.22
Morphology of cells and hemagglutinogens of Bordetella species: resolution of substructural units in fimbriae of Bordetella pertussis. Infect Immun (1983) 1.19
Newborn rabbit alveolar macrophages are deficient in two microbicidal cationic peptides, MCP-1 and MCP-2. Am Rev Respir Dis (1985) 1.17
Production and properties of Bordetella pertussis heat-labile toxin. J Med Microbiol (1984) 1.13
Repressor binding to a regulatory site in the DNA coding sequence is sufficient to confer transcriptional regulation of the vir-repressed genes (vrg genes) in Bordetella pertussis. J Bacteriol (1993) 1.08
Pasteurella multocida and Bordetella bronchiseptica infections in rabbits. J Clin Microbiol (1990) 1.08
Long-term survival of Bordetella bronchiseptica in lakewater and in buffered saline without added nutrients. FEMS Microbiol Lett (1993) 1.02
Cloning of Bordetella bronchiseptica urease genes and analysis of colonization by a urease-negative mutant strain in a guinea-pig model. Mol Microbiol (1993) 0.93
High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Res (1988) 34.78
Cell to cell interaction in the immune response. II. The source of hemolysin-forming cells in irradiated mice given bone marrow and thymus or thoracic duct lymphocytes. J Exp Med (1968) 12.91
Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature (1998) 11.08
Cell to cell interaction in the immune response. I. Hemolysin-forming cells in neonatally thymectomized mice reconstituted with thymus or thoracic duct lymphocytes. J Exp Med (1968) 9.67
Thymus and antigen-reactive cells. Transplant Rev (1969) 8.84
Current concepts of the immunological function of the thymus. Physiol Rev (1967) 8.37
Immunological activity of thymus and thoracic-duct lymphocytes. Proc Natl Acad Sci U S A (1968) 7.49
A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med (1972) 7.47
Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med (1997) 5.72
Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med (1996) 5.21
Cell to cell interaction in the immune response. 3. Chromosomal marker analysis of single antibody-forming cells in reconstituted, irradiated, or thymectomized mice. J Exp Med (1968) 5.02
Sequences required for expression of Bordetella pertussis virulence factors share homology with prokaryotic signal transduction proteins. Proc Natl Acad Sci U S A (1989) 4.78
Specific inactivation of thymus-derived (T) and non-thymus-derived (B) lymphocytes by 125I-labelled antigen. Nat New Biol (1971) 4.55
Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med (1997) 4.01
The thymus and the precursors of antigen reactive cells. Nature (1967) 3.92
Role of major histocompatibility complex gene products in delayed-type hypersensitivity. Proc Natl Acad Sci U S A (1976) 3.69
Cellular basis of the immunological defects in thymectomized mice. Nature (1967) 3.69
Ectopic expression of the flagellar regulon alters development of the Bordetella-host interaction. Cell (1995) 3.64
Antigen-induced selective recruitment of circulating lymphocytes. Cell Immunol (1971) 3.35
H-2 gene complex restricts transfer of delayed-type hypersensitivity in mice. Proc Natl Acad Sci U S A (1975) 3.34
Regeneration of thymus grafts. I. Histological and cytological aspects. Transplantation (1965) 3.29
Roles for motility in bacterial-host interactions. Mol Microbiol (1997) 3.16
Cell to cell interaction in the immune response. IV. Site of action of antilymphocyte globulin. J Exp Med (1968) 3.16
Cell-to-cell interaction in the immune response. VI. Contribution of thymus-derived cells and antibody-forming cell precursors to immunological memory. J Exp Med (1971) 3.14
T cell-dependent suppression of an anti-hapten antibody response. Transplant Rev (1975) 3.06
Interaction between lymphocytes in immune responses. Cell Immunol (1971) 3.03
Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. J Exp Med (1976) 3.00
Early embryonic mortality in women. Fertil Steril (1982) 2.92
Cell-to-cell interaction in the immune response. X. T-cell-dependent suppression in tolerant mice. J Exp Med (1974) 2.77
Fetal loss after implantation. A prospective study. Lancet (1980) 2.73
Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes. Nature (1991) 2.67
Screening for receptor ligands using large libraries of peptides linked to the C terminus of the lac repressor. Proc Natl Acad Sci U S A (1992) 2.67
Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity. Proc Natl Acad Sci U S A (1995) 2.66
A radioisotopic method to measure delayed type hypersensitivity in the mouse. I. Studies in sensitized and normal mice. Int Arch Allergy Appl Immunol (1975) 2.64
Compartmentalization of bacterial antigens: differential effects on priming of CD8 T cells and protective immunity. Cell (1998) 2.59
CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med (1997) 2.49
Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic beta cells. Nature (1988) 2.46
Integration of multiple domains in a two-component sensor protein: the Bordetella pertussis BvgAS phosphorelay. EMBO J (1996) 2.41
Growth of B-lymphocyte colonies in vitro. J Exp Med (1975) 2.41
Peripheral deletion of self-reactive B cells. Nature (1991) 2.34
The bvgAS locus negatively controls motility and synthesis of flagella in Bordetella bronchiseptica. J Bacteriol (1992) 2.33
The bvgA gene of Bordetella pertussis encodes a transcriptional activator required for coordinate regulation of several virulence genes. J Bacteriol (1989) 2.29
Activation of thymus cells by histocompatibility antigens. Nat New Biol (1971) 2.26
The role of the thymus and recent thymic migrants in the maintenance of the adult peripheral lymphocyte pool. J Exp Med (1998) 2.25
Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med (1998) 2.24
Growth of B lymphocyte colonies in vitro from mouse lymphoid organs. Nature (1975) 2.24
Tolerance of class I histocompatibility antigens expressed extrathymically. Nature (1989) 2.19
MICROBIOME. A unified initiative to harness Earth's microbiomes. Science (2015) 2.15
Enrichment of specific suppressor T cells and characterization of their surface markers. J Exp Med (1977) 2.13
Thymus-derived cells in mouse thoracic duct lymph. Nat New Biol (1971) 2.07
A mutation in the Bordetella bronchiseptica bvgS gene results in reduced virulence and increased resistance to starvation, and identifies a new class of Bvg-regulated antigens. Mol Microbiol (1997) 2.01
Specific suppressive factors produced by hybridomas derived from the fusion of enriched suppressor T cells and a T lymphoma cell line. J Exp Med (1978) 2.01
The BvgAS virulence control system regulates type III secretion in Bordetella bronchiseptica. Mol Microbiol (1998) 1.99
Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection. Immunol Cell Biol (2000) 1.98
Flagellin gene transcription in Bordetella bronchiseptica is regulated by the BvgAS virulence control system. J Bacteriol (1993) 1.94
Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature (1992) 1.92
Effect of thymectomy in adult mice on immunological responsiveness. Nature (1965) 1.91
Receptor for antibody-antigen complexes used to separate T cells from B cells. Nat New Biol (1972) 1.87
Prevention of diabetes in non-obese diabetic I-Ak transgenic mice. Nature (1990) 1.87
The immune response of normal, irradiated and thymectomized mice to fowl immunoglobulin G as detected by a hemolytic plaque technique. Int Arch Allergy Appl Immunol (1971) 1.85
Pregenomic comparative analysis between bordetella bronchiseptica RB50 and Bordetella pertussis tohama I in murine models of respiratory tract infection. Infect Immun (1999) 1.83
Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J Exp Med (1998) 1.83
Cross-presentation: a general mechanism for CTL immunity and tolerance. Immunol Today (1998) 1.82
Interaction of thymus lymphocytes with histoincompatible cells. II. Recirculating lymphocytes derived from antigen-activated thymus cells. Cell Immunol (1972) 1.78
Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection. Infect Immun (2000) 1.77
Probing the function of Bordetella bronchiseptica adenylate cyclase toxin by manipulating host immunity. Infect Immun (1999) 1.76
Filamentous hemagglutinin of Bordetella bronchiseptica is required for efficient establishment of tracheal colonization. Infect Immun (1998) 1.74
Modulation of host immune responses, induction of apoptosis and inhibition of NF-kappaB activation by the Bordetella type III secretion system. Mol Microbiol (2000) 1.73
Autogenous regulation of the Bordetella pertussis bvgABC operon. Proc Natl Acad Sci U S A (1990) 1.72
Species- and strain-specific control of a complex, flexible regulon by Bordetella BvgAS. J Bacteriol (2006) 1.70
Induction of autoimmune diabetes by oral administration of autoantigen. Science (1996) 1.69
Comparative analysis of the virulence control systems of Bordetella pertussis and Bordetella bronchiseptica. Mol Microbiol (1996) 1.69
Interaction of thymus lymphocytes with histoincompatible cells. I. Quantitation of the proliferative response of thymus cells. Cell Immunol (1972) 1.68
The immunological responsiveness of germ-free mice thymectomized at birth. I. Antibody production and skin homograft rejection. Clin Exp Immunol (1967) 1.66
Autophosphorylation and phosphotransfer in the Bordetella pertussis BvgAS signal transduction cascade. Proc Natl Acad Sci U S A (1994) 1.65
In vivo studies of DnaA binding to the origin of replication of Escherichia coli. EMBO J (1989) 1.60
Effect of recent antigen priming on adoptive immune responses. I. Specific unresponsiveness of cells from lymphoid organs of mice primed with heterologous erythrocytes. J Exp Med (1973) 1.58
Relationship between Fc receptors, antigen-binding sites on T and B cells, and H-2 complex-associated determinants. J Exp Med (1975) 1.58
Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. Immunity (2001) 1.58
Cell to cell interaction in the immune response. V. Target cells for tolerance induction. J Exp Med (1970) 1.55
CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc Natl Acad Sci U S A (1999) 1.55
Thymus and the production of antibody-plaque-forming cells. Nature (1965) 1.54
Expression of two alpha chains on the surface of T cells in T cell receptor transgenic mice. J Exp Med (1993) 1.53
Mechanisms of Bordetella pathogenesis. Front Biosci (2001) 1.52
The relation between age and mean length of utterance in morphemes. J Speech Hear Res (1981) 1.52
Site of action of antilymphocyte globulin. Lancet (1967) 1.51
The thymus. Yesterday, today, and tomorrow. Lancet (1967) 1.50
A comparison of T cell memory against the same antigen induced by virus versus intracellular bacteria. Proc Natl Acad Sci U S A (1999) 1.49
Interaction of thymus lymphocytes with histoincompatible cells. 3. Immunological characteristics of recirculating lymphocytes derived from activated thymus cells. Cell Immunol (1972) 1.49
Identification and characterization of BipA, a Bordetella Bvg-intermediate phase protein. Mol Microbiol (2001) 1.47
The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). J Exp Med (1998) 1.47
Hapten-specific tolerance: unresponsiveness in the T cell-depleted population. Eur J Immunol (1973) 1.47
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents. J Med Chem (1998) 1.46
Cell-to-cell interaction in the immune response. VII. Requirement for differentiation of thymus-derived cells. J Exp Med (1971) 1.46
Cardiac output responses of primigravid women during exercise determined by the direct Fick technique. Obstet Gynecol (1990) 1.44
Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter. Proc Natl Acad Sci U S A (1989) 1.44
The nu gene acts cell-autonomously and is required for differentiation of thymic epithelial progenitors. Proc Natl Acad Sci U S A (1996) 1.43
Clonal deletion of autospecific B lymphocytes. Immunol Rev (1991) 1.42
An idiotypic determinant formed by both immunoglobulin constant and variable regions. Nature (1983) 1.42
Effect of neonatal thymectomy on the induction of sarcomata in C57 BL mice. Nature (1965) 1.42